Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Loxo Oncology, Inc. (LOXO)

« Back to company index

LOXO Chatter Timeline

Stock Ticker for LOXO

Most Active Tweeters for LOXO

No tweets found

Recent Tweets for LOXO

beyond_ninety @beyond_ninety
Opaleye Management Lifted Its Loxo Oncology $LOXO Position; Windacre Partnership Has Decreased Its Transdigm Group… https://t.co/a1nP0WZ32e
August 21st 2018, 7:08pm
moneyjunto @moneyjunto
$LOXO lets go. Biotech needs to start breaking out and it will.
August 21st 2018, 1:08pm
usindexlive @usindexlive
Prudential Financial Lowered Loxo Oncology $LOXO Position as Stock Rose; Pru $PRU Shareholder Davenport & Company H… https://t.co/OATi5PiYa2
August 21st 2018, 12:08pm
MareaInformativ @MareaInformativ
Zacks: Brokerages Anticipate Loxo Oncology Inc $LOXO Will Announce Earnings of -$0.53 Per Share https://t.co/ttxuc0OjGT
August 20th 2018, 6:08pm
dakotafinancial @dakotafinancial
Zacks: Brokerages Anticipate Loxo Oncology Inc $LOXO Will Announce Earnings of -$0.53 Per Share https://t.co/r5mcKnfX9p
August 20th 2018, 5:08pm
registrarjourn @registrarjourn
Loxo Oncology Inc $LOXO Shares Sold by Frontier Capital Management Co. LLC https://t.co/7mw2p3E3C9
August 20th 2018, 1:08pm
EnterpriseLeade @EnterpriseLeade
Loxo Oncology Inc $LOXO Shares Sold by Frontier Capital Management Co. LLC https://t.co/NZpkk2BKO9
August 20th 2018, 1:08pm
registrarjourn @registrarjourn
Stifel Nicolaus Trims Loxo Oncology $LOXO Target Price to $217.00 https://t.co/zN7kGXGhs3
August 20th 2018, 12:08pm
EnterpriseLeade @EnterpriseLeade
Stifel Nicolaus Trims Loxo Oncology $LOXO Target Price to $217.00 https://t.co/cRmQfd4N9R
August 20th 2018, 12:08pm
MareaInformativ @MareaInformativ
Loxo Oncology $LOXO Given Media Impact Score of 0.16 https://t.co/7pUYWwChVF
August 20th 2018, 9:08am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Downgrades Loxo Oncology $LOXO to Hold https://t.co/72YejqH1PS
August 20th 2018, 2:08am
beyond_ninety @beyond_ninety
As Loxo Oncology $LOXO Market Valuation Rose, Sands Capital Management Has Decreased Stake; Maple Capital Managemen… https://t.co/2V4bP4Uuye
August 19th 2018, 2:08pm
registrarjourn @registrarjourn
Loxo Oncology’s $LOXO Buy Rating Reiterated at Cowen https://t.co/1hBWZzdXws
August 19th 2018, 1:08pm
EnterpriseLeade @EnterpriseLeade
Loxo Oncology Inc $LOXO Shares Sold by KBC Group NV https://t.co/XE5uT26hFg
August 19th 2018, 10:08am
TheMarketsDaily @TheMarketsDaily
Loxo Oncology $LOXO Downgraded by Zacks Investment Research https://t.co/0dnpkAexZr
August 19th 2018, 10:08am
MareaInformativ @MareaInformativ
Loxo Oncology $LOXO Price Target Cut to $217.00 https://t.co/I8EUeUBFPv
August 18th 2018, 7:08pm
dailypoliticaln @dailypoliticaln
Zacks: Analysts Expect Loxo Oncology Inc $LOXO Will Post Earnings of -$0.53 Per Share https://t.co/J5aUogNQVo
August 18th 2018, 2:08pm
ZolmaxNews @ZolmaxNews
Zacks: Brokerages Expect Loxo Oncology Inc $LOXO Will Announce Earnings of -$0.53 Per Share https://t.co/ypnbMu2RPL
August 18th 2018, 2:08pm
MichelDoepke @MichelDoepke
$LOXO and $BAYN - pact against #cancer. #Bayer https://t.co/IE4O8KGMiv
August 18th 2018, 1:08pm
TranscriptDaily @TranscriptDaily
Loxo Oncology Inc $LOXO VP Jennifer Burstein Sells 2,500 Shares https://t.co/kIGM8KVGD8
August 18th 2018, 12:08pm
TranscriptDaily @TranscriptDaily
Loxo Oncology Inc $LOXO VP Jennifer Burstein Sells 2,500 Shares https://t.co/GI3Uqyttyo
August 18th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Loxo Oncology Inc $LOXO Stake Lessened by EAM Investors LLC https://t.co/fgttckS0LT
August 18th 2018, 11:08am
OlympiaReport @OlympiaReport
Loxo Oncology Inc $LOXO Insider Sells $1,593,400.00 in Stock https://t.co/waF0fyJTlx
August 18th 2018, 5:08am
WeekHerald @WeekHerald
Loxo Oncology Inc $LOXO Insider Naarden Jacob Van Sells 10,000 Shares https://t.co/855skpAOkS
August 18th 2018, 5:08am
TickerReport @TickerReport
Loxo Oncology $LOXO Stock Rating Lowered by Zacks Investment Research https://t.co/ZBhppWf9Xa
August 18th 2018, 2:08am
dailypoliticaln @dailypoliticaln
Zacks Investment Research Lowers Loxo Oncology $LOXO to Hold https://t.co/UZ6wUmWX5N
August 18th 2018, 2:08am
RockPaperMoon @RockPaperMoon
RT @EnterpriseLeade: Somewhat Positive News Coverage Somewhat Unlikely to Affect Loxo Oncology $LOXO Stock Price https://t.co/XTkKEU7AfG
August 18th 2018, 2:08am
EnterpriseLeade @EnterpriseLeade
Somewhat Positive News Coverage Somewhat Unlikely to Affect Loxo Oncology $LOXO Stock Price https://t.co/XTkKEU7AfG
August 18th 2018, 2:08am
BillKoski2 @BillKoski2
Round 2 on $LOXO. What do you think? Worth the hype or overvalued? https://t.co/pcmNH7fZ4f
August 17th 2018, 4:08pm
ChartMill @ChartMill
$LOXO has an Altman-Z score of 8.66, meaning it is financially healthy with little risk of bankruptcy.… https://t.co/qOFql02YHY
August 17th 2018, 3:08pm
ZolmaxNews @ZolmaxNews
Insider Selling: Loxo Oncology Inc $LOXO VP Sells 2,500 Shares of Stock https://t.co/tfTcVFoVki
August 17th 2018, 2:08pm
dailypoliticaln @dailypoliticaln
Jennifer Burstein Sells 2,500 Shares of Loxo Oncology Inc $LOXO Stock https://t.co/JzOBqCa4eP
August 17th 2018, 2:08pm
EnterpriseLeade @EnterpriseLeade
Loxo Oncology $LOXO Downgraded to “Hold” at Zacks Investment Research https://t.co/UQlEOSSnav
August 17th 2018, 1:08pm
WeekHerald @WeekHerald
Loxo Oncology $LOXO Downgraded to “Hold” at Zacks Investment Research https://t.co/jisb5Hg7ow
August 17th 2018, 1:08pm
registrarjourn @registrarjourn
Emerald Mutual Fund Advisers Trust Purchases New Position in Loxo Oncology Inc $LOXO https://t.co/o5QGSn8y5d
August 17th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Emerald Mutual Fund Advisers Trust Purchases New Position in Loxo Oncology Inc $LOXO https://t.co/AlAcjdwj9B
August 17th 2018, 11:08am
TranscriptDaily @TranscriptDaily
Naarden Jacob Van Sells 10,000 Shares of Loxo Oncology Inc $LOXO Stock https://t.co/5u0WIfDjmp
August 17th 2018, 8:08am
EnterpriseLeade @EnterpriseLeade
Loxo Oncology Inc $LOXO CEO Sells $3,188,200.00 in Stock https://t.co/uB2KdmQHWm
August 17th 2018, 7:08am
dakotafinancial @dakotafinancial
Zacks: Brokerages Expect Loxo Oncology Inc $LOXO Will Announce Quarterly Sales of $47.07 Million https://t.co/6qGlw927MY
August 17th 2018, 7:08am
dakotafinancial @dakotafinancial
Zacks: Brokerages Expect Loxo Oncology Inc $LOXO Will Announce Quarterly Sales of $47.07 Million https://t.co/Bk8ON8NhNS
August 17th 2018, 5:08am
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Loxo Oncology Inc $LOXO Will Announce Quarterly Sales of $47.07 Million https://t.co/fgrNSBmN2O #stocks
August 17th 2018, 5:08am
WatchlistN @WatchlistN
Loxo Oncology Inc $LOXO VP Jennifer Burstein Sells 2,500 Shares https://t.co/PWraT68Jc6
August 16th 2018, 2:08pm
TickerReport @TickerReport
Loxo Oncology Inc $LOXO VP Jennifer Burstein Sells 2,500 Shares https://t.co/IxasKtp0L4
August 16th 2018, 2:08pm
ConsumerFeed @ConsumerFeed
Insider Selling: Loxo Oncology Inc $LOXO CEO Sells 20,000 Shares of Stock https://t.co/VemVPw1agB
August 16th 2018, 1:08pm
ConsumerFeed @ConsumerFeed
Loxo Oncology Inc $LOXO Insider Sells $1,593,400.00 in Stock https://t.co/vbszEsfe7b
August 16th 2018, 1:08pm
registrarjourn @registrarjourn
Zacks: Brokerages Anticipate Loxo Oncology Inc $LOXO Will Post Earnings of $0.12 Per Share https://t.co/orCY0OEk3r
August 16th 2018, 12:08pm
The_CasualSmart @The_CasualSmart
The Insider Naarden Van Unloaded 10000 shares of Loxo Oncology, Inc. $LOXO; L Brands $LB SI Increased By 4.38% https://t.co/h4CoNUSfWS
August 16th 2018, 6:08am
The_CasualSmart @The_CasualSmart
What after Jennifer Burstein's Insider Sale of Loxo Oncology, Inc. $LOXO Stock?; Bryn Mawr Trust Company Trimmed In… https://t.co/uvMQgElhol
August 16th 2018, 6:08am
bbnsnews @bbnsnews
Zacks Investment Research Lowers Loxo Oncology $LOXO to Hold https://t.co/akxAsyCzzD
August 16th 2018, 6:08am
beyond_ninety @beyond_ninety
Rhenman & Partners Asset Management Ab Has Cut Loxo Oncology $LOXO Holding By $1.76 Million; Whale Rock Capital Man… https://t.co/QVUvlWsjNB
August 16th 2018, 5:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.